Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02090920 · ClinicalTrials.gov registry record

Individualized Dosing of Nifedipine For Tocolysis in Preterm Labor

A clinical trial of Preterm Labor, sponsored by Indiana University.

Completed
Registry status
20
Enrollment target
2
Study locations

NCT02090920 is a study of Preterm Labor that has completed, run by Indiana University. The registered enrollment target is 20 participants, below the 6,080-participant average among 8 other Preterm Labor trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02090920, a study of Preterm Labor, has completed, sponsored by Indiana University.

COMPLETED
Registry status
20 participants
Enrollment target
2
Study locations

Study Summary

This study looks at the effects of a mother's genes and other characteristics (mother's age, baby's age, race, and other diseases) on the ability of nifedipine to end contractions and prevent an early delivery. This information will be used to decide what amount of nifedipine women need to best treat preterm contractions.

Conditions Studied

Preterm Labor

Interventions

  • DRUG Nifedipine

Study Locations (2)

Indiana

  • Eskenazi Health - Indianapolis
  • IU Health Methodist - Indianapolis

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2011-07
Est. Completion 2019-04

Sponsor

Indiana University

890 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02090920

The ClinicalTrials.gov registry entry for NCT02090920 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,080-participant average among 8 other Preterm Labor trials with a reported enrollment target (100% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Preterm Labor appearing as the primary indexed condition, and to 1 intervention - of which Nifedipine is the first listed.

NCT02090920 reports 2 study locations spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT02090920 about?

NCT02090920 is a clinical study titled "Individualized Dosing of Nifedipine For Tocolysis in Preterm Labor". This study looks at the effects of a mother's genes and other characteristics (mother's age, baby's age, race, and other diseases) on the ability of nifedipine to end contractions and prevent an early delivery. This information will be used to decide what amount of nifedipine women need to best trea...

What is the current status of trial NCT02090920?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2011-07. Estimated completion is 2019-04.

What conditions does trial NCT02090920 study?

This clinical trial studies the following conditions: Preterm Labor.

What interventions are being tested in trial NCT02090920?

The interventions under investigation include: Nifedipine (DRUG).

Who is sponsoring clinical trial NCT02090920?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02090920 being conducted?

This trial has 2 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Preterm Labor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Preterm Labor

All registered trials for this condition

Indiana

All trials with a study site in Indiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.